Therapy - Bone Marrow
"400 Autotransplants (AT) for Multiple Myeloma (MM)."
Published in Cancer Weekly, March 6th, 1995
According to an abstract submitted by the authors to the 36th Annual Meeting of the American Society of Hematology, held December 2-6, 1994, in Nashville, Tennessee, "Lack of progress in the treatment of MM has prompted exploration of myeloablative therapy with autologous transplants (AT) as a means of effecting more marked tumor cytoreduction and thereby improving prognosis. Since 1985, 400 pts have undergone AT. The initial 55 pts received bone marrow (ABMT, <30% plasmacytosis) in support of TBI 850 cGy with either melphalan 140 mg/M2 (MEL 140) or thiotepa 750 mg/M2. Since 1990, 2 AT were intended within 12 mos using peripheral blood stem cells (PBSC ±...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-03-06)
More Articles from Cancer Weekly
- Cancer/Gene Therapy
Adoptive Immunotherapy by Gene Transfection for Metastatic Disease Treatment - Cancer/Gene Therapy
Retroviral-Mediated Gene Transfer Enhances Antitumor Immunity - Cancer/Gene Therapy
"Suicide Gene" Shows Promise Against Localized Gliomas - Cervical Cancer
Blood Test Detects Virus Linked to Cancer - Colorectal
Alcohol and Smoking Cited As Risk Factors for Polyps - Conference Coverage
Advances in Prognostic Evaluation of Cervical Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
